Hepzato Kit
NDC Package 75833-601-07
Package Information
Hepzato Kit (melphalan hydrochloride injection, powder, lyophilized, for solution) kits is hEPZATO for injection, as a component of the HEPZATO KIT, is indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation. This formulation utilizes a kit delivery system. Marketed by Delcath Systems, Inc., this product is identified by NDC 75833-601 and is authorized under FDA application NDA201848.
Identification & Billing
- RxCUI: 2671196 - HEPZATO 50 MG Injection
- RxCUI: 2671196 - melphalan 50 MG Injection [Hepzato]
- RxCUI: 2671196 - Hepzato 50 MG Injection
- RxCUI: 311487 - melphalan 50 MG Injection
- RxCUI: 311487 - melphalan (as melphalan hydrochloride) 50 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 75833 - Delcath Systems, Inc.
- 75833-601 - Hepzato Kit
- 75833-601-07 - 1 KIT in 1 BOX * 5 VIAL, SINGLE-USE in 1 BOX (75833-700-01) / 10 mL in 1 VIAL, SINGLE-USE * 2 BAG in 1 BOX (75833-444-01) / 250 mL in 1 BAG * 5 VIAL, SINGLE-USE in 1 BOX (75833-800-01) / 10 mL in 1 VIAL, SINGLE-USE
- 75833-601 - Hepzato Kit
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (75833-601). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 75833-601-07 identifies a specific commercial package of 1 kit in 1 box * 5 vial, single-use in 1 box (75833-700-01) / 10 ml in 1 vial, single-use * 2 bag in 1 box (75833-444-01) / 250 ml in 1 bag * 5 vial, single-use in 1 box (75833-800-01) / 10 ml in 1 vial, single-use of Hepzato Kit, a human prescription drug labeled by Delcath Systems, Inc.. This kit is formulated for intra-arterial use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Delcath Systems, Inc. on December 04, 2023. The current certification is valid through December 31, 2027.
How is this Delcath Systems, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 75833060107. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.